ResearcherDaegu Catholic UniversityNo recent work listed

Sang Hoon Joo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8660-884X; OpenAlex author ID A5103083777. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

MS-5, a Naphthalene Derivative, Induces Apoptosis in Human Pancreatic Cancer BxPC-3 Cells by Modulating Reactive Oxygen Species. Last author DOI 10.4062/biomolther.2022.127 ↗
ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. First author DOI 10.1007/s12272-021-01359-x ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Suman Giri · 1 shared paper, 2023 · strength 0.22
- Paper MS-5, a Naphthalene Derivative, Induces Apoptosis in Human Pancreatic Cancer BxPC-3 Cells by Modulating Reactive Oxygen… DOI 10.4062/biomolther.2022.127 ↗
Won‐Jun Jang · 1 shared paper, 2021 · strength 0.16
- Paper ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. DOI 10.1007/s12272-021-01359-x ↗
Seongjun Park · 1 shared paper, 2021 · strength 0.16
- Paper ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. DOI 10.1007/s12272-021-01359-x ↗
Chul‐Ho Jeong · 1 shared paper, 2021 · strength 0.16
- Paper ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. DOI 10.1007/s12272-021-01359-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.